LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Nicolaidou, Paola"
  2. AU=Selvidge S D
  3. AU=Gonzalez-Alcaide Gregorio
  4. AU=Van Allen Eliezer M.
  5. AU="Lim, Adrian"
  6. AU="Roloff-Handschin, Tim-Christoph"
  7. AU="Portocarrero, Carla P"
  8. AU=Sokouti Massoud

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel: Inherited metabolic disorders in Cyprus.

    Georgiou, Theodoros / Petrou, Petros P / Malekkou, Anna / Ioannou, Ioannis / Gavatha, Marina / Skordis, Nicos / Nicolaidou, Paola / Savvidou, Irini / Athanasiou, Emilia / Ourani, Sofia / Papamichael, Elena / Vogazianos, Marios / Dionysiou, Maria / Mavrikiou, Gabriella / Grafakou, Olga / Tanteles, George A / Anastasiadou, Violetta / Drousiotou, Anthi

    Molecular genetics and metabolism reports

    2024  Band 39, Seite(n) 101083

    Abstract: Selective screening for inherited metabolic disorders (IMD) began in Cyprus in 1990. Over the last thirty-three years 7388 patients were investigated for IMD and 200 diagnoses were made (diagnostic yield 2.7%). The existence of a single laboratory of ... ...

    Abstract Selective screening for inherited metabolic disorders (IMD) began in Cyprus in 1990. Over the last thirty-three years 7388 patients were investigated for IMD and 200 diagnoses were made (diagnostic yield 2.7%). The existence of a single laboratory of Biochemical Genetics for the whole island facilitated the creation of a national registry for IMD. The minimal prevalence of IMD in Cyprus is 53.3 cases per 100,000 live births. The most common group are disorders of amino acid metabolism (41.0%), followed by disorders of carbohydrate metabolism (16.5%), disorders of complex molecule degradation (16.5%), mitochondrial disorders (10.5%) and disorders of vitamin and co-factor metabolism (5.5%). Hyperphenylalaninaemia is the most common IMD (14.0%) followed by galactosaemia (7.0%), glutaric aciduria type I (5.5%) and MSUD (4.0%). Some disorders were found to have a relatively high incidence in specific communities, for example Sandhoff disease among the Cypriot Maronites and GM1 gangliosidosis in one particular area of the island. Other disorders were found to have a relatively higher overall incidence, compared to other Caucasian populations, for example galactosaemia, glutaric aciduria type I and MSUD, while fatty acid oxidation defects, Gaucher disease and classic PKU were found to have a relatively lower incidence. Molecular characterization of selected disorders revealed many novel genetic variants, specific to the Cypriot population.
    Sprache Englisch
    Erscheinungsdatum 2024-04-23
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2821908-9
    ISSN 2214-4269
    ISSN 2214-4269
    DOI 10.1016/j.ymgmr.2024.101083
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Molecular analysis of Cypriot patients with Glutaric aciduria type I: identification of two novel mutations.

    Georgiou, Theodoros / Nicolaidou, Paola / Hadjichristou, Anastasia / Ioannou, Rodothea / Dionysiou, Maria / Siama, Elli / Chappa, Georgia / Anastasiadou, Violetta / Drousiotou, Anthi

    Clinical biochemistry

    2014  Band 47, Heft 13-14, Seite(n) 1300–1305

    Abstract: Objectives: The purpose of this study was to identify the mutations in the glutaryl-CoA dehydrogenase gene (GCDH) in ten Cypriot patients with Glutaric aciduria type I (GAI).: Design and methods: Molecular analysis of the GCDH gene was performed by ... ...

    Abstract Objectives: The purpose of this study was to identify the mutations in the glutaryl-CoA dehydrogenase gene (GCDH) in ten Cypriot patients with Glutaric aciduria type I (GAI).
    Design and methods: Molecular analysis of the GCDH gene was performed by direct sequencing of the patients' genomic DNA. In silico tools were applied to predict the effect of the novel variants on the structure and function of the protein.
    Results: All disease alleles were characterized (mutation detection rate 100%). Five missense mutations were identified: c.192G>T (p.Glu64Asp) and c.803G>T (p.Gly268Val), which are novel, and three previously described mutations, c.1123T>C (p.Cys375Arg), c.1204C>T (p.Arg402Trp) and c.1286C>T (p.Thr429Met).
    Conclusions: Two novel mutations, p.Glu64Asp and p.Gly268Val, account for the majority of disease alleles (76.5%) in Cypriot patients with Glutaric aciduria type I. A founder effect for the p.Glu64Asp and the p.Gly268Val can be suggested based on the place of origin of the carriers of these mutations. Identification of the causative mutations of GAI in Cypriot patients will facilitate carrier detection as well as post- and pre-natal diagnosis.
    Mesh-Begriff(e) Adolescent ; Adult ; Alleles ; Amino Acid Metabolism, Inborn Errors/genetics ; Brain Diseases, Metabolic/genetics ; Child ; Child, Preschool ; Female ; Genetic Carrier Screening ; Glutaryl-CoA Dehydrogenase/deficiency ; Glutaryl-CoA Dehydrogenase/genetics ; Humans ; Male ; Mutation, Missense/genetics ; Young Adult
    Chemische Substanzen Glutaryl-CoA Dehydrogenase (EC 1.3.8.6)
    Sprache Englisch
    Erscheinungsdatum 2014-09
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 390372-2
    ISSN 1873-2933 ; 0009-9120
    ISSN (online) 1873-2933
    ISSN 0009-9120
    DOI 10.1016/j.clinbiochem.2014.06.017
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang